Robert Reis
Concepts (475)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caenorhabditis elegans | 33 | 2024 | 146 | 4.080 |
Why?
| Longevity | 21 | 2019 | 87 | 2.270 |
Why?
| Alzheimer Disease | 9 | 2024 | 367 | 1.880 |
Why?
| Caenorhabditis elegans Proteins | 12 | 2019 | 60 | 1.670 |
Why?
| Aging | 21 | 2016 | 784 | 1.430 |
Why?
| Mutation | 19 | 2023 | 1501 | 0.990 |
Why?
| Phosphatidylinositol 3-Kinases | 6 | 2016 | 153 | 0.980 |
Why?
| Neurodegenerative Diseases | 4 | 2022 | 83 | 0.970 |
Why?
| Animals | 60 | 2024 | 14385 | 0.870 |
Why?
| Chromosome Mapping | 12 | 2006 | 175 | 0.810 |
Why?
| Recombination, Genetic | 14 | 2011 | 108 | 0.790 |
Why?
| Gene Regulatory Networks | 3 | 2019 | 124 | 0.780 |
Why?
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 64 | 0.730 |
Why?
| Quantitative Trait Loci | 6 | 2006 | 51 | 0.720 |
Why?
| DNA | 18 | 2021 | 581 | 0.720 |
Why?
| Phosphatidylinositol Phosphates | 3 | 2018 | 15 | 0.670 |
Why?
| DNA, Mitochondrial | 7 | 2017 | 186 | 0.610 |
Why?
| Rad51 Recombinase | 4 | 2015 | 21 | 0.530 |
Why?
| Genomic Instability | 2 | 2020 | 95 | 0.520 |
Why?
| Proteins | 4 | 2018 | 376 | 0.520 |
Why?
| 14-3-3 Proteins | 2 | 2022 | 24 | 0.520 |
Why?
| Telomerase | 5 | 2017 | 30 | 0.500 |
Why?
| Aspirin | 2 | 2017 | 127 | 0.470 |
Why?
| Multiple Myeloma | 6 | 2020 | 3035 | 0.460 |
Why?
| Oxidative Stress | 6 | 2012 | 958 | 0.450 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 7 | 0.450 |
Why?
| Profilins | 2 | 2023 | 18 | 0.450 |
Why?
| Humans | 68 | 2023 | 54246 | 0.420 |
Why?
| Amyloid beta-Peptides | 4 | 2021 | 82 | 0.420 |
Why?
| Peptide Nucleic Acids | 3 | 2015 | 17 | 0.420 |
Why?
| Benzylamines | 1 | 2021 | 18 | 0.410 |
Why?
| Cholinesterase Inhibitors | 1 | 2021 | 25 | 0.400 |
Why?
| Huntington Disease | 1 | 2021 | 27 | 0.400 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2021 | 7 | 0.400 |
Why?
| Alkaloids | 1 | 2021 | 37 | 0.400 |
Why?
| Glutathione Transferase | 3 | 2006 | 178 | 0.390 |
Why?
| Thiadiazoles | 1 | 2020 | 15 | 0.380 |
Why?
| Peptide Fragments | 4 | 2021 | 242 | 0.380 |
Why?
| Hematologic Neoplasms | 1 | 2022 | 99 | 0.380 |
Why?
| RNA | 2 | 2021 | 202 | 0.370 |
Why?
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.370 |
Why?
| Lysosomes | 3 | 2024 | 91 | 0.370 |
Why?
| Brain | 3 | 2018 | 1387 | 0.370 |
Why?
| Stress, Physiological | 4 | 2015 | 194 | 0.370 |
Why?
| Neuroprotective Agents | 1 | 2021 | 125 | 0.370 |
Why?
| Disease Models, Animal | 7 | 2021 | 1639 | 0.360 |
Why?
| RNA Interference | 7 | 2016 | 195 | 0.360 |
Why?
| Transcription, Genetic | 8 | 2015 | 418 | 0.340 |
Why?
| Transcriptome | 2 | 2019 | 346 | 0.340 |
Why?
| Fibroblasts | 21 | 2001 | 386 | 0.340 |
Why?
| Somatomedins | 1 | 2018 | 29 | 0.340 |
Why?
| DNA-Binding Proteins | 5 | 2021 | 462 | 0.340 |
Why?
| Simian virus 40 | 6 | 2002 | 13 | 0.330 |
Why?
| Hippocampus | 2 | 2021 | 242 | 0.330 |
Why?
| DNA Replication | 7 | 2017 | 152 | 0.330 |
Why?
| Protein Binding | 5 | 2018 | 736 | 0.330 |
Why?
| Hot Temperature | 4 | 2013 | 199 | 0.330 |
Why?
| Autophagy | 2 | 2024 | 202 | 0.320 |
Why?
| Gene Expression Profiling | 5 | 2015 | 1138 | 0.320 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2018 | 131 | 0.320 |
Why?
| Codon, Nonsense | 3 | 2016 | 29 | 0.320 |
Why?
| Lasers | 2 | 2021 | 141 | 0.310 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 151 | 0.310 |
Why?
| Nucleotide Motifs | 1 | 2017 | 29 | 0.310 |
Why?
| Membrane Proteins | 2 | 2018 | 389 | 0.300 |
Why?
| Insulin | 2 | 2018 | 510 | 0.300 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.290 |
Why?
| Models, Genetic | 2 | 2015 | 209 | 0.290 |
Why?
| Computational Biology | 1 | 2018 | 231 | 0.290 |
Why?
| Muscles | 1 | 2016 | 114 | 0.280 |
Why?
| Antigens, Polyomavirus Transforming | 4 | 2002 | 7 | 0.280 |
Why?
| Caloric Restriction | 2 | 2015 | 37 | 0.280 |
Why?
| Molecular Docking Simulation | 3 | 2023 | 83 | 0.280 |
Why?
| Telomere | 4 | 2004 | 36 | 0.280 |
Why?
| Pyridinium Compounds | 1 | 2015 | 17 | 0.280 |
Why?
| Cyclin-Dependent Kinases | 1 | 2015 | 35 | 0.270 |
Why?
| Aldehydes | 2 | 2006 | 97 | 0.270 |
Why?
| Homologous Recombination | 1 | 2015 | 43 | 0.270 |
Why?
| Proprotein Convertases | 1 | 2015 | 8 | 0.270 |
Why?
| Benzimidazoles | 1 | 2015 | 54 | 0.270 |
Why?
| Polymerase Chain Reaction | 8 | 2008 | 531 | 0.260 |
Why?
| Mice | 15 | 2024 | 6413 | 0.260 |
Why?
| DNA Transposable Elements | 6 | 2005 | 82 | 0.260 |
Why?
| Serine Endopeptidases | 1 | 2015 | 57 | 0.260 |
Why?
| Repetitive Sequences, Nucleic Acid | 9 | 2000 | 92 | 0.260 |
Why?
| Myocytes, Smooth Muscle | 1 | 2015 | 92 | 0.250 |
Why?
| Protein Conformation | 3 | 2020 | 226 | 0.250 |
Why?
| Lipids | 2 | 2016 | 178 | 0.250 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 198 | 0.250 |
Why?
| Melphalan | 1 | 2015 | 180 | 0.250 |
Why?
| Bone Density | 4 | 2006 | 416 | 0.250 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 110 | 0.240 |
Why?
| Proteomics | 3 | 2018 | 343 | 0.240 |
Why?
| Cell Transformation, Neoplastic | 5 | 2001 | 200 | 0.240 |
Why?
| Cell Line | 10 | 2018 | 1153 | 0.230 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.230 |
Why?
| Aedes | 1 | 2013 | 9 | 0.230 |
Why?
| Cell Division | 13 | 2004 | 330 | 0.230 |
Why?
| Drug Resistance, Neoplasm | 1 | 2015 | 309 | 0.230 |
Why?
| Indoles | 2 | 2020 | 289 | 0.230 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 474 | 0.220 |
Why?
| Cell Survival | 10 | 2015 | 657 | 0.220 |
Why?
| Gametogenesis | 1 | 2012 | 1 | 0.220 |
Why?
| Scavenger Receptors, Class E | 1 | 2015 | 217 | 0.220 |
Why?
| Quantitative Trait, Heritable | 3 | 2001 | 30 | 0.210 |
Why?
| Cell Transformation, Viral | 4 | 2002 | 27 | 0.210 |
Why?
| Computer Simulation | 3 | 2018 | 332 | 0.210 |
Why?
| Photoacoustic Techniques | 1 | 2013 | 86 | 0.210 |
Why?
| Metal Nanoparticles | 1 | 2013 | 96 | 0.210 |
Why?
| Microscopy, Confocal | 1 | 2012 | 110 | 0.210 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 125 | 0.210 |
Why?
| Binding Sites | 3 | 2020 | 440 | 0.200 |
Why?
| Cell Line, Tumor | 6 | 2015 | 1550 | 0.200 |
Why?
| Data Mining | 1 | 2011 | 38 | 0.200 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 4 | 2001 | 21 | 0.200 |
Why?
| Gold | 1 | 2013 | 164 | 0.200 |
Why?
| Alu Elements | 1 | 2011 | 9 | 0.200 |
Why?
| Fluorescent Dyes | 1 | 2012 | 116 | 0.200 |
Why?
| Down-Regulation | 2 | 2011 | 388 | 0.200 |
Why?
| Signal Transduction | 4 | 2018 | 1753 | 0.200 |
Why?
| Cells, Cultured | 16 | 2016 | 1737 | 0.200 |
Why?
| Cell Line, Transformed | 7 | 2017 | 88 | 0.200 |
Why?
| Barrett Esophagus | 1 | 2011 | 28 | 0.200 |
Why?
| Esophageal Neoplasms | 2 | 2011 | 100 | 0.190 |
Why?
| Oxyquinoline | 1 | 2020 | 7 | 0.190 |
Why?
| Animals, Genetically Modified | 4 | 2018 | 52 | 0.190 |
Why?
| Chelating Agents | 1 | 2020 | 28 | 0.190 |
Why?
| Dependovirus | 2 | 2002 | 102 | 0.190 |
Why?
| Gene Expression Regulation | 4 | 2009 | 1062 | 0.190 |
Why?
| Plasmids | 8 | 2005 | 180 | 0.190 |
Why?
| Werner Syndrome | 4 | 1991 | 14 | 0.190 |
Why?
| Genome, Human | 1 | 2011 | 131 | 0.190 |
Why?
| Models, Molecular | 3 | 2020 | 423 | 0.190 |
Why?
| Histoplasma | 1 | 2009 | 29 | 0.180 |
Why?
| Obesity | 1 | 2018 | 1197 | 0.180 |
Why?
| Genetic Markers | 5 | 2003 | 117 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1476 | 0.180 |
Why?
| Drug Design | 1 | 2020 | 133 | 0.180 |
Why?
| Multigene Family | 3 | 1997 | 54 | 0.180 |
Why?
| Histoplasmosis | 1 | 2009 | 53 | 0.170 |
Why?
| Enzyme Inhibitors | 2 | 2003 | 446 | 0.170 |
Why?
| Bone and Bones | 1 | 2003 | 516 | 0.170 |
Why?
| Lipid Peroxidation | 2 | 2007 | 132 | 0.170 |
Why?
| Catalytic Domain | 2 | 2020 | 62 | 0.170 |
Why?
| Biopolymers | 1 | 2008 | 14 | 0.170 |
Why?
| Peptides | 2 | 2021 | 276 | 0.170 |
Why?
| Pattern Recognition, Automated | 1 | 2008 | 45 | 0.160 |
Why?
| Amino Acid Sequence | 2 | 2021 | 767 | 0.160 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2008 | 70 | 0.160 |
Why?
| Sequence Alignment | 1 | 2008 | 146 | 0.160 |
Why?
| Bone Diseases, Metabolic | 2 | 2000 | 82 | 0.160 |
Why?
| Spine | 2 | 2006 | 111 | 0.160 |
Why?
| RNA, Messenger | 9 | 2017 | 1202 | 0.160 |
Why?
| Adenocarcinoma | 2 | 2011 | 428 | 0.160 |
Why?
| DNA, Circular | 6 | 1990 | 22 | 0.160 |
Why?
| Antineoplastic Agents | 2 | 2015 | 1300 | 0.160 |
Why?
| Replication Origin | 1 | 2017 | 11 | 0.160 |
Why?
| RNA, Transfer | 1 | 2017 | 25 | 0.150 |
Why?
| Artificial Intelligence | 1 | 2008 | 85 | 0.150 |
Why?
| Genotype | 5 | 2017 | 599 | 0.150 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.150 |
Why?
| Models, Animal | 3 | 2019 | 255 | 0.150 |
Why?
| Ubiquitin | 2 | 2018 | 51 | 0.150 |
Why?
| Molecular Dynamics Simulation | 2 | 2017 | 40 | 0.140 |
Why?
| Chorionic Gonadotropin | 4 | 1990 | 15 | 0.140 |
Why?
| Selection, Genetic | 1 | 2005 | 27 | 0.140 |
Why?
| Growth Inhibitors | 1 | 2005 | 32 | 0.140 |
Why?
| Receptor, Insulin | 1 | 2005 | 44 | 0.140 |
Why?
| Apoptosis | 3 | 2004 | 1300 | 0.130 |
Why?
| Genes, Helminth | 2 | 2006 | 5 | 0.130 |
Why?
| Phosphorylation | 2 | 2017 | 614 | 0.130 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 206 | 0.130 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2015 | 219 | 0.130 |
Why?
| Point Mutation | 1 | 2005 | 92 | 0.130 |
Why?
| Cell Death | 2 | 2016 | 223 | 0.130 |
Why?
| Up-Regulation | 2 | 2011 | 508 | 0.130 |
Why?
| Genes, Viral | 2 | 2002 | 43 | 0.120 |
Why?
| Hydrogen Peroxide | 3 | 2016 | 142 | 0.120 |
Why?
| Algorithms | 1 | 2008 | 697 | 0.120 |
Why?
| Oxazoles | 1 | 2004 | 9 | 0.120 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 866 | 0.120 |
Why?
| Genetic Predisposition to Disease | 2 | 2006 | 570 | 0.120 |
Why?
| Porphyrins | 1 | 2003 | 12 | 0.120 |
Why?
| Viral Proteins | 2 | 2002 | 158 | 0.110 |
Why?
| Guanosine Triphosphate | 1 | 2023 | 23 | 0.110 |
Why?
| Cloning, Molecular | 8 | 2000 | 198 | 0.110 |
Why?
| Reactive Oxygen Species | 3 | 2015 | 491 | 0.110 |
Why?
| Tubulin | 1 | 2023 | 28 | 0.110 |
Why?
| Transfection | 5 | 2008 | 399 | 0.110 |
Why?
| Genes | 5 | 1996 | 38 | 0.110 |
Why?
| Models, Biological | 7 | 2009 | 823 | 0.110 |
Why?
| Microtubules | 1 | 2023 | 57 | 0.110 |
Why?
| Forkhead Transcription Factors | 3 | 2009 | 118 | 0.110 |
Why?
| Life Expectancy | 2 | 2012 | 40 | 0.110 |
Why?
| Drosophila melanogaster | 2 | 2015 | 24 | 0.100 |
Why?
| Time Factors | 5 | 2019 | 3212 | 0.100 |
Why?
| Hematopoiesis | 1 | 2022 | 80 | 0.100 |
Why?
| Electrophorus | 1 | 2021 | 5 | 0.100 |
Why?
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.100 |
Why?
| Geriatrics | 1 | 2012 | 47 | 0.100 |
Why?
| Osteoporosis | 1 | 2003 | 164 | 0.100 |
Why?
| Acetylcholinesterase | 1 | 2021 | 21 | 0.100 |
Why?
| Gene Deletion | 2 | 2006 | 293 | 0.100 |
Why?
| Epistasis, Genetic | 2 | 2017 | 42 | 0.100 |
Why?
| Horses | 1 | 2021 | 51 | 0.100 |
Why?
| Protein Folding | 1 | 2021 | 52 | 0.100 |
Why?
| Coronary Artery Disease | 1 | 2005 | 329 | 0.100 |
Why?
| Actins | 3 | 2018 | 132 | 0.100 |
Why?
| Taq Polymerase | 1 | 2000 | 6 | 0.100 |
Why?
| Ataxia Telangiectasia | 2 | 1999 | 5 | 0.100 |
Why?
| Base Pair Mismatch | 1 | 2000 | 24 | 0.100 |
Why?
| Food Deprivation | 1 | 2000 | 29 | 0.100 |
Why?
| Disease Progression | 2 | 2017 | 913 | 0.100 |
Why?
| Hypertension | 1 | 2016 | 563 | 0.090 |
Why?
| Fungi | 2 | 1997 | 48 | 0.090 |
Why?
| Molecular Structure | 1 | 2021 | 319 | 0.090 |
Why?
| Drosophila | 2 | 1997 | 17 | 0.090 |
Why?
| RNA, Viral | 1 | 2021 | 141 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 475 | 0.090 |
Why?
| Glioma | 1 | 2021 | 78 | 0.090 |
Why?
| Hematopoietic Stem Cells | 1 | 2022 | 215 | 0.090 |
Why?
| Cell Cycle | 4 | 2004 | 275 | 0.090 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 423 | 0.090 |
Why?
| RNA-Binding Proteins | 1 | 2021 | 136 | 0.090 |
Why?
| Trans-Activators | 1 | 2001 | 147 | 0.090 |
Why?
| Loss of Heterozygosity | 2 | 2011 | 97 | 0.090 |
Why?
| Anisomycin | 1 | 2019 | 3 | 0.090 |
Why?
| Dipyrone | 1 | 2019 | 3 | 0.090 |
Why?
| Proteome | 1 | 2021 | 178 | 0.090 |
Why?
| Camptothecin | 1 | 2019 | 16 | 0.090 |
Why?
| Benzazepines | 1 | 2019 | 20 | 0.090 |
Why?
| Transcription Factors | 3 | 2009 | 622 | 0.090 |
Why?
| Azacitidine | 1 | 2019 | 37 | 0.090 |
Why?
| Species Specificity | 3 | 2006 | 205 | 0.090 |
Why?
| Survival Rate | 2 | 2013 | 951 | 0.090 |
Why?
| DNA Helicases | 1 | 2001 | 132 | 0.090 |
Why?
| Protein Unfolding | 1 | 2018 | 5 | 0.080 |
Why?
| Gene Expression | 5 | 2006 | 664 | 0.080 |
Why?
| Male | 13 | 2018 | 27312 | 0.080 |
Why?
| Hydrogen Bonding | 1 | 2018 | 45 | 0.080 |
Why?
| Drug Evaluation | 1 | 2008 | 27 | 0.080 |
Why?
| DNA Damage | 3 | 2015 | 357 | 0.080 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 42 | 0.080 |
Why?
| Mutant Proteins | 1 | 2018 | 41 | 0.080 |
Why?
| Age Factors | 5 | 2016 | 1195 | 0.080 |
Why?
| DNA Nucleotidyltransferases | 1 | 1997 | 1 | 0.080 |
Why?
| Base Sequence | 7 | 1997 | 719 | 0.080 |
Why?
| Aging, Premature | 1 | 1997 | 6 | 0.080 |
Why?
| Mutagenicity Tests | 1 | 1997 | 56 | 0.080 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.080 |
Why?
| Integrases | 1 | 1997 | 45 | 0.080 |
Why?
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.080 |
Why?
| Halothane | 1 | 1997 | 2 | 0.080 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 74 | 0.080 |
Why?
| Mice, Knockout | 2 | 2015 | 926 | 0.080 |
Why?
| Nematoda | 1 | 1997 | 2 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 514 | 0.080 |
Why?
| Pharmaceutical Preparations | 1 | 2008 | 86 | 0.080 |
Why?
| Mammals | 3 | 2006 | 57 | 0.080 |
Why?
| Anesthetics, Inhalation | 1 | 1997 | 35 | 0.080 |
Why?
| Acetylation | 1 | 2017 | 99 | 0.080 |
Why?
| Absorptiometry, Photon | 3 | 2006 | 174 | 0.070 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.070 |
Why?
| Detergents | 1 | 2016 | 17 | 0.070 |
Why?
| Carrier Proteins | 1 | 2018 | 359 | 0.070 |
Why?
| Mice, Transgenic | 1 | 2018 | 656 | 0.070 |
Why?
| Thermodynamics | 1 | 2016 | 43 | 0.070 |
Why?
| tau Proteins | 1 | 2016 | 30 | 0.070 |
Why?
| Solubility | 1 | 2016 | 75 | 0.070 |
Why?
| Carcinogens | 1 | 1997 | 231 | 0.070 |
Why?
| Indolizines | 1 | 2015 | 11 | 0.070 |
Why?
| Cyclic N-Oxides | 1 | 2015 | 15 | 0.070 |
Why?
| Synteny | 1 | 2005 | 7 | 0.070 |
Why?
| Mole Rats | 1 | 2015 | 1 | 0.070 |
Why?
| Ligands | 1 | 2016 | 230 | 0.070 |
Why?
| Chromosomes, Human, X | 1 | 2005 | 21 | 0.070 |
Why?
| Principal Component Analysis | 1 | 2015 | 71 | 0.070 |
Why?
| S Phase | 1 | 2015 | 19 | 0.070 |
Why?
| Mice, SCID | 1 | 2015 | 196 | 0.070 |
Why?
| Drug Synergism | 1 | 2015 | 171 | 0.070 |
Why?
| Skin | 3 | 1991 | 469 | 0.070 |
Why?
| Diploidy | 4 | 1997 | 30 | 0.070 |
Why?
| Genes, BRCA1 | 1 | 2015 | 24 | 0.070 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 41 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2006 | 552 | 0.070 |
Why?
| Crosses, Genetic | 3 | 2005 | 31 | 0.070 |
Why?
| Alleles | 2 | 2009 | 277 | 0.060 |
Why?
| Neoplasms | 1 | 2005 | 1315 | 0.060 |
Why?
| Fertility | 1 | 2014 | 33 | 0.060 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 141 | 0.060 |
Why?
| Protein Multimerization | 1 | 2014 | 54 | 0.060 |
Why?
| Promoter Regions, Genetic | 2 | 2008 | 520 | 0.060 |
Why?
| Lipopolysaccharides | 1 | 2015 | 199 | 0.060 |
Why?
| Mitochondria | 1 | 2008 | 489 | 0.060 |
Why?
| Phylogeny | 1 | 1995 | 269 | 0.060 |
Why?
| Cytokines | 1 | 2017 | 676 | 0.060 |
Why?
| Methylation | 7 | 1990 | 130 | 0.060 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2007 | 151 | 0.060 |
Why?
| Phenotype | 2 | 2003 | 820 | 0.060 |
Why?
| Sequence Deletion | 1 | 1994 | 99 | 0.060 |
Why?
| Lipoproteins, LDL | 1 | 2015 | 195 | 0.060 |
Why?
| NF-kappa B | 1 | 2015 | 335 | 0.060 |
Why?
| Mice, Congenic | 1 | 2003 | 8 | 0.060 |
Why?
| Genetic Techniques | 1 | 2003 | 15 | 0.060 |
Why?
| Blotting, Western | 1 | 2014 | 683 | 0.060 |
Why?
| Endothelial Cells | 1 | 2015 | 294 | 0.060 |
Why?
| DNA Restriction Enzymes | 6 | 1990 | 16 | 0.060 |
Why?
| Case-Control Studies | 1 | 2016 | 1228 | 0.060 |
Why?
| Genes, Essential | 1 | 2012 | 14 | 0.060 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 204 | 0.050 |
Why?
| Biological Evolution | 1 | 2012 | 37 | 0.050 |
Why?
| Systems Biology | 1 | 2012 | 33 | 0.050 |
Why?
| Young Adult | 2 | 2016 | 4308 | 0.050 |
Why?
| Melanins | 1 | 2012 | 30 | 0.050 |
Why?
| Intracellular Space | 1 | 2012 | 31 | 0.050 |
Why?
| Radiation Dosage | 1 | 2013 | 170 | 0.050 |
Why?
| Databases, Genetic | 1 | 2012 | 101 | 0.050 |
Why?
| Locomotion | 1 | 2012 | 83 | 0.050 |
Why?
| Ribosomes | 1 | 1981 | 33 | 0.050 |
Why?
| Gene Amplification | 3 | 1985 | 57 | 0.050 |
Why?
| Glycoside Hydrolases | 1 | 1991 | 27 | 0.050 |
Why?
| Clone Cells | 3 | 1997 | 89 | 0.050 |
Why?
| Gene Expression Regulation, Viral | 2 | 2002 | 50 | 0.050 |
Why?
| Poly A | 1 | 1990 | 14 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2012 | 218 | 0.050 |
Why?
| Female | 9 | 2017 | 28418 | 0.050 |
Why?
| Oxidants | 1 | 2011 | 64 | 0.050 |
Why?
| Glycoprotein Hormones, alpha Subunit | 1 | 1990 | 1 | 0.050 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 171 | 0.050 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.050 |
Why?
| Protein Structure, Secondary | 1 | 2020 | 99 | 0.050 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1990 | 7 | 0.050 |
Why?
| Genes, ras | 1 | 1990 | 48 | 0.050 |
Why?
| Fatty Acids | 1 | 2011 | 174 | 0.050 |
Why?
| Cytosine | 2 | 1990 | 29 | 0.050 |
Why?
| HEK293 Cells | 1 | 2020 | 245 | 0.040 |
Why?
| Aphidicolin | 2 | 2001 | 3 | 0.040 |
Why?
| Microscopy | 1 | 2009 | 66 | 0.040 |
Why?
| Reference Values | 2 | 2016 | 354 | 0.040 |
Why?
| Adult | 6 | 2016 | 14182 | 0.040 |
Why?
| Protein Biosynthesis | 1 | 1981 | 273 | 0.040 |
Why?
| Nucleic Acid Hybridization | 5 | 1985 | 54 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1056 | 0.040 |
Why?
| Hydroxyurea | 2 | 2001 | 29 | 0.040 |
Why?
| Proto-Oncogene Proteins | 1 | 1990 | 169 | 0.040 |
Why?
| DNA Primers | 2 | 2000 | 225 | 0.040 |
Why?
| Virulence | 1 | 2009 | 194 | 0.040 |
Why?
| Aged, 80 and over | 1 | 2016 | 3429 | 0.040 |
Why?
| Aged | 7 | 2016 | 10041 | 0.040 |
Why?
| Evolution, Molecular | 1 | 2009 | 103 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 143 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2008 | 252 | 0.040 |
Why?
| Oogenesis | 1 | 2007 | 17 | 0.040 |
Why?
| Diet | 1 | 2012 | 597 | 0.040 |
Why?
| Lesch-Nyhan Syndrome | 2 | 1997 | 2 | 0.040 |
Why?
| Electroporation | 2 | 2004 | 17 | 0.040 |
Why?
| Histones | 1 | 1989 | 335 | 0.040 |
Why?
| Genes, Insect | 1 | 2006 | 7 | 0.040 |
Why?
| Gene Library | 2 | 2000 | 50 | 0.040 |
Why?
| Antigens, Viral, Tumor | 2 | 2001 | 6 | 0.040 |
Why?
| Middle Aged | 4 | 2016 | 13070 | 0.040 |
Why?
| Mutagenesis | 1 | 2006 | 77 | 0.040 |
Why?
| Mutagens | 1 | 2006 | 81 | 0.040 |
Why?
| Tissue Distribution | 1 | 2016 | 178 | 0.030 |
Why?
| Environment | 1 | 2006 | 103 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 48 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2008 | 1089 | 0.030 |
Why?
| Electrophoresis | 1 | 2005 | 18 | 0.030 |
Why?
| Regression Analysis | 1 | 2006 | 445 | 0.030 |
Why?
| Liver | 1 | 1981 | 1225 | 0.030 |
Why?
| Oncogenes | 1 | 1985 | 63 | 0.030 |
Why?
| Isoenzymes | 1 | 2005 | 177 | 0.030 |
Why?
| Insulin-Like Growth Factor I | 1 | 2005 | 137 | 0.030 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 209 | 0.030 |
Why?
| Rats | 2 | 2005 | 3415 | 0.030 |
Why?
| Ultraviolet Rays | 2 | 1997 | 56 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2006 | 643 | 0.030 |
Why?
| Oligonucleotide Probes | 2 | 1996 | 21 | 0.030 |
Why?
| Stress, Psychological | 1 | 2006 | 269 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2005 | 217 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 206 | 0.030 |
Why?
| Sex Factors | 1 | 2006 | 765 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2005 | 234 | 0.030 |
Why?
| Deoxyribonuclease I | 1 | 2003 | 41 | 0.030 |
Why?
| Animals, Congenic | 1 | 2003 | 4 | 0.030 |
Why?
| Animals, Inbred Strains | 1 | 2003 | 5 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 2003 | 477 | 0.030 |
Why?
| DNA Repair | 1 | 2004 | 202 | 0.030 |
Why?
| G-Quadruplexes | 1 | 2003 | 81 | 0.030 |
Why?
| Internationality | 1 | 2012 | 49 | 0.030 |
Why?
| Nucleic Acid Denaturation | 2 | 1985 | 14 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1995 | 980 | 0.030 |
Why?
| Kinetics | 3 | 1991 | 692 | 0.030 |
Why?
| DNA, Viral | 1 | 2002 | 142 | 0.020 |
Why?
| Helper Viruses | 1 | 2001 | 6 | 0.020 |
Why?
| False Positive Reactions | 1 | 2001 | 68 | 0.020 |
Why?
| Homozygote | 1 | 2001 | 60 | 0.020 |
Why?
| Heterozygote | 1 | 2001 | 96 | 0.020 |
Why?
| Templates, Genetic | 1 | 2000 | 17 | 0.020 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 2000 | 6 | 0.020 |
Why?
| Sequence Homology | 1 | 2000 | 21 | 0.020 |
Why?
| Larva | 1 | 2000 | 23 | 0.020 |
Why?
| Mice, Inbred AKR | 1 | 2000 | 7 | 0.020 |
Why?
| Blotting, Northern | 2 | 1991 | 108 | 0.020 |
Why?
| DNA, Complementary | 1 | 2000 | 145 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2001 | 193 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2001 | 177 | 0.020 |
Why?
| Heat-Shock Proteins | 1 | 2000 | 87 | 0.020 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 1999 | 14 | 0.020 |
Why?
| Enzyme Induction | 1 | 1999 | 80 | 0.020 |
Why?
| Mice, Inbred C57BL | 2 | 1997 | 1999 | 0.020 |
Why?
| Invertebrates | 1 | 1989 | 3 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2005 | 847 | 0.020 |
Why?
| Drug Therapy | 1 | 2008 | 50 | 0.020 |
Why?
| Aminopterin | 1 | 1997 | 2 | 0.020 |
Why?
| Molecular Probes | 1 | 1988 | 13 | 0.020 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 44 | 0.020 |
Why?
| Recombinases | 1 | 1997 | 8 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 923 | 0.020 |
Why?
| Hypoxanthine | 1 | 1997 | 4 | 0.020 |
Why?
| Viral Structural Proteins | 1 | 1997 | 6 | 0.020 |
Why?
| Thymidine | 1 | 1997 | 18 | 0.020 |
Why?
| Sexual Behavior, Animal | 1 | 1997 | 4 | 0.020 |
Why?
| Transformation, Genetic | 1 | 1997 | 19 | 0.020 |
Why?
| Culture Media | 1 | 1997 | 100 | 0.020 |
Why?
| Drug Resistance | 1 | 1997 | 74 | 0.020 |
Why?
| Methotrexate | 1 | 1997 | 73 | 0.020 |
Why?
| Centrifugation, Density Gradient | 1 | 1985 | 26 | 0.020 |
Why?
| DNA, Recombinant | 1 | 1985 | 17 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1985 | 6 | 0.020 |
Why?
| DNA, Helminth | 1 | 1995 | 2 | 0.020 |
Why?
| Research Design | 1 | 1988 | 374 | 0.020 |
Why?
| Glucocorticoids | 1 | 1997 | 234 | 0.020 |
Why?
| Haplotypes | 1 | 2005 | 105 | 0.020 |
Why?
| Dexamethasone | 1 | 1997 | 435 | 0.020 |
Why?
| Femur | 1 | 2005 | 144 | 0.020 |
Why?
| Linear Models | 1 | 2005 | 309 | 0.020 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 105 | 0.020 |
Why?
| Base Composition | 2 | 1985 | 25 | 0.020 |
Why?
| Blotting, Southern | 1 | 1994 | 40 | 0.020 |
Why?
| Child | 4 | 1985 | 7337 | 0.020 |
Why?
| Escherichia coli | 1 | 1985 | 250 | 0.010 |
Why?
| Extrachromosomal Inheritance | 1 | 1983 | 3 | 0.010 |
Why?
| Globins | 2 | 1982 | 14 | 0.010 |
Why?
| Poly U | 1 | 1981 | 5 | 0.010 |
Why?
| Polyribosomes | 1 | 1981 | 8 | 0.010 |
Why?
| Cell-Free System | 1 | 1981 | 16 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 1981 | 39 | 0.010 |
Why?
| alpha-Mannosidase | 1 | 1991 | 5 | 0.010 |
Why?
| beta-N-Acetylhexosaminidases | 1 | 1991 | 6 | 0.010 |
Why?
| Mannosidases | 1 | 1991 | 12 | 0.010 |
Why?
| beta-Galactosidase | 1 | 1991 | 42 | 0.010 |
Why?
| Glucuronidase | 1 | 1991 | 48 | 0.010 |
Why?
| Nucleotide Mapping | 1 | 1990 | 2 | 0.010 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1990 | 3 | 0.010 |
Why?
| Nucleotides | 1 | 1990 | 23 | 0.010 |
Why?
| Genes, Regulator | 1 | 1990 | 5 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1990 | 12 | 0.010 |
Why?
| Restriction Mapping | 1 | 1990 | 32 | 0.010 |
Why?
| DNA Probes | 1 | 1990 | 27 | 0.010 |
Why?
| Contact Inhibition | 1 | 1989 | 3 | 0.010 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 69 | 0.010 |
Why?
| Gene Rearrangement | 1 | 1989 | 76 | 0.010 |
Why?
| Genetic Variation | 1 | 1990 | 253 | 0.010 |
Why?
| Glycoproteins | 1 | 1989 | 132 | 0.010 |
Why?
| Treatment Outcome | 1 | 2008 | 5604 | 0.010 |
Why?
| Breeding | 1 | 1996 | 10 | 0.010 |
Why?
| 5-Methylcytosine | 1 | 1985 | 18 | 0.010 |
Why?
| Catalase | 1 | 1996 | 74 | 0.010 |
Why?
| Superoxide Dismutase | 1 | 1996 | 125 | 0.010 |
Why?
| Temperature | 1 | 1985 | 177 | 0.010 |
Why?
| Analysis of Variance | 1 | 1996 | 635 | 0.010 |
Why?
| Lymphocytes | 2 | 1985 | 168 | 0.010 |
Why?
| Proto-Oncogenes | 1 | 1985 | 29 | 0.000 |
Why?
| Chromosomes, Human | 1 | 1985 | 45 | 0.000 |
Why?
|
|
Reis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|